Sulphated compounds attenuate β-amyloid toxicity by inhibiting its association with cells

NeuroReport

Volumn 7, Issue 1, 1995, Pages 49-53

  Sadler, Isobel I J ^a   Smith, David W ^a   Shearman, Mark S ^a   Ragan, C Ian ^a   Tailor, Vipula J ^a   Pollack, Scott J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Alzheimer s disease; Cell association; Congo red; Elisa; Glycosaminoglycan; MTT; Neurotoxicity; Sulphate; Sulphonate; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN; CARRAGEENAN; CHONDROITIN SULFATE; CONGO RED; DERMATAN SULFATE; DEXTRAN; DEXTRAN SULFATE; FLUORESCENT DYE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; HYALURONIC ACID; PENTOSAN SULFATE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HELA CELL; HUMAN; HUMAN CELL; NEUROTOXICITY; PRIORITY JOURNAL; SULFATION;

AMYLOID BETA-PROTEIN; COLORING AGENTS; CONGO RED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HELA CELLS; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SULFATES; SULFONIC ACIDS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 0029549796     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/00001756-199512290-00011     Document Type: Article

References (26)

1. Fraser PE, Levesque L, McLachlan DR. Clin Biochem 26, 339-349 (1993).
2. Snow AD, Wight TN. Neurobiol Aging 10, 481-497 (1989).
3. Su JH, Cummings BJ, Cotman CW. Neuroscience 51, 801-813 (1992).
4. Brunden KR, Richter-Cook NJ, Chaturvedi N et al. J Neurochem 61, 2147-2154 (1993).
5. Buee L, Ding W, Anderson JP et al. Brain Res 627, 199-204 (1993).
6. Leveugle B, Scanameo A, Ding W et al. NeuroReport 5, 1389-1392 (1994).
7. Fraser PE, Nguyen JT, Chin DT et al. J Neurochem 59, 1531-1540 (1992).
8. Kisilevsky R. Lab Invest 63, 589-591 (1990).
9. Kisilevsky R, Lyon AW and Young ID. Crit Rev Clin Lab Sci 29, 59-82 (1992).
10. Pike CJ, Burdick D, Walencewicz AJ et al. J Neurosci 13,1676-1687 (1993).
11. Shearman MS, Ragan CI and Iversen LL. Proc Natl Acad Sci USA 91, 1470-1471 (1993).
12. Simmons LK, May PC, Tomaselli KJ et al. Mol Pharmacol 45, 373-379 (1994).
13. Ueda K, Fukui T, Kageyama H. Brain Res 639, 240-244 (1994).
14. Pollack SJ, Sadler IIJ, Hawtin SR et al. Neurosci Lett 184, 113-116(1995).
15. Yankner BA, Duffy LK and Kirschner DA. Science 250, 279-281 (1990).
16. Pollack SJ, Sadler IIJ, Hawtin SR et al. Neurosci Lett in press.
17. Caughey B, Raymond GJ. J Virol 67, 643-650 (1993).
18. Kisilevsky R, Lemieux LJ, Fraser PE et al. Nature Med 1, 143-148 (1995).
19. Lorenzo A, Yankner BA. Proc Natl Acad Sci USA 91, 12243-12247 (1994).
20. McCubbin WD, Kay CM, Narindrasorasak S et al. Biochem J 256, 775-783 (1988).
21. Iversen LL, Mortishire-Smith RJ, Pollack SJ et al. Biochem J in press.
22. Klunk WE, Pettegrew JW, Abraham DJ. J Histochem Cytochem 37,1273-1281 (1989).
23. Shearman MS, Hawtin SR, Tailor VJ. J Neurochem 65, 218-227 (1995).
24. Hansen MB, Nielsen SE and Berg K. J Immunol Methods 119,203-210 (1989).
25. Behl C, Davis JB, Lesley R et al. Cell 77, 817-827 (1994).
26. Podlisny MB, Ostaszewski BL, Squazzo SL et al. J Biol Chem 270, 9564-9570 (1995).